Amlodipine And Atorvastatin Tablet, Film Coated
Product Images NDC 72162-2092

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Amlodipine And Atorvastatin (NDC 72162-2092). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Amlodipine Besylate And Atorvastatin Calcium 02)

Figure 1 (Amlodipine Besylate And Atorvastatin Calcium 02)
This text appears to be a statistical analysis report. It provides information about an event rate, p-value, hazard ratio, and confidence interval. The event rate is not specified, so it is not possible to determine the context of the analysis. The p-value is 0.003, indicating a statistically significant result. The hazard ratio is 0.691, suggesting a reduced risk or effect. The 95% confidence interval ranges from 0.54 to 0.88. The remaining text seems to be unrelated or incomplete.*
FDA Label Image

Figure 2 (Amlodipine Besylate And Atorvastatin Calcium 03)

FDA Label Image

Figure 3 (Amlodipine Besylate And Atorvastatin Calcium 04)

FDA Label Image

Figure 4 (Amlodipine Besylate And Atorvastatin Calcium 05)

FDA Label Image

Figure 5 (Amlodipine Besylate And Atorvastatin Calcium 06)

Figure 5 (Amlodipine Besylate And Atorvastatin Calcium 06)
Subjects were evaluated for the occurrence of events while taking different doses of Atorvastatin. The results showed a decrease in the occurrence of events in subjects taking Atorvastatin 10 mg and Atorvastatin 80 mg compared to the control group. The hazard ratio was 0.78 (0.69-0.89) with a p-value of 0.0002, indicating a significant reduction in events with Atorvastatin treatment. The graph shows the time to the first major cardiovascular endpoint over the course of several years.*
FDA Label Image

Amlodipine (Amlodipine)

FDA Label Image

Atorvastatin-glycol-solvate (Atorvastatin Glycol Solvate)

FDA Label Image

Label (Lbl721622092)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.